share_log

Needham:重申Cara Therapeutics(CARA.US)评级,由买入调整至买入评级, 目标价5.00美元。

Needham: Reiterates Cara Therapeutics (CARA.US) rating and adjusted from buy to buy rating, target price of $5.00.

Zhitong Finance ·  Apr 10, 2024 10:40
Needham: Reiterates Cara Therapeutics (CARA.US) rating and adjusted from buy to buy rating, target price of $5.00.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment

    Statement

    This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.